Limitations of double-blind trials
نویسندگان
چکیده
منابع مشابه
Limitations of the Double-Blind Pharmaceutical Study:
This paper examines the limitations of the double-blind pharmaceutical study in medical research. These areas are often neglected. First, common difficulties are discussed. These include lack of appropriate demographic controls including cigarettes, alcohol, caffeine and drug interactions. Additionally, not eliciting side-effects and therapeutic effects may occur because the measuring instrumen...
متن کاملDouble-blind clinical trials of oral cyclacillin and ampicillin.
A double-blind study was performed to compare the clinical response and the incidence of side effects in 2,581 patients administered ampicillin or cyclacillin for infections of the genitourinary or respiratory tract, infections of the skin and soft tissues, or for otitis media. There was no significant difference in clinical response and bacterial eradication. All side effects, including diarrh...
متن کاملNonathymulin in rheumatoid arthritis: two double blind, placebo controlled trials.
Two randomised double blind, placebo controlled trials have been carried out to assess the effectiveness of nonathymulin, a synthetic thymic peptide hormone, in the treatment of rheumatoid arthritis (RA) and to compare three different dosage schedules (1, 5, and 10 mg/day). Nonathymulin 5 mg proved to be the most efficient dose, providing significant clinical improvement as evaluated by the glo...
متن کاملLimitations of "pragmatic" trials.
C linical trials testing the value of therapeutic interventions range between the two extremes of maximal internal or external validity. The former study, often called an efficacy trial, tests a treatment under optimal (that is, near laboratory) conditions, in which features such as the patient sample, the intervention, and the outcome measures are narrowly defined. Their research question is u...
متن کاملDouble-blind active-control trials: beware the comparator you keep.
The indirect impact of the known comparator drug in double-blind comparative clinical trials of novel agents is underappreciated, despite its potentially pernicious effects. This hypothesis-generating analysis illustrates potential spillover effects of a comparator (amphotericin) in the evaluation of the first member (caspofungin) of a novel class (echinocandins) of antifungal drugs. Reported r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Psychiatry
سال: 1990
ISSN: 0007-1250,1472-1465
DOI: 10.1192/bjp.157.2.300b